The Washington State Department of Health said Tuesday that it was made aware of the recent death of the woman in King County.
Public Health Seattle & King County said Tuesday the woman was the fourth person in the United States to die due to blood clotting issues following the J&J vaccine.
Three deaths were reported before federal authorities temporarily halted J&J vaccinations in April. A spokesperson for the Centers for Disease Control and Prevention says the agency is aware of, and is looking into, additional reported clot deaths since then, including the one in Washington state.
The King County woman received her shot on Aug. 26. She died on Sept. 7.
Blood clots are a very rare complication associated with J&J’s vaccine.
According to King County authorities, 12.5 million doses of the J&J vaccine had been administered as of July 8, 2021, with 38 people having confirmed cases of the unusual type of blood clot. The majority of these people have recovered.
U.S. health officials have concluded the benefits of J&J’s single-dose vaccine outweigh the rare risk of blood clots.
Administration of the vaccine was halted for 11 days in April over the clots. After the shots resumed, J&J vaccine recipients were warned of the symptoms to watch for and health care workers were given guidance on how to treat the clots.
"Sadly, this is the first such death in Washington State. We send our deepest condolences to her family and loved ones. Losing a loved one at any time is a tragic and difficult and pain that’s become all too familiar in the last year and a half of this pandemic." said Umair A. Shah, MD, MPH, Secretary of Health.
Also on Tuesday, Johnson & Johnson said it has asked the U.S. Food and Drug Administration to authorize a booster shot for its single-dose COVID-19 vaccine as the government looks to expand its booster program.
Stay connected with FOX 13 News on all platforms:
DOWNLOAD: FOX 13 News and Weather Apps
WATCH: FOX 13 News Live
SUBSCRIBE: FOX 13 on YouTube
DAILY BRIEF: Sign Up For Our Newsletter
FOLLOW: Facebook | Twitter | Instagram